See also this year's filing and all EDGAR filings for this company.
PDF Report 0001740547_2019_Urovant_Sciences_Ltd.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001740547, Urovant Sciences Ltd
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 12,390,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 510,000 |
| 3 | remainder_Assets | 84,000 |
| 4 | LiabilitiesCurrent | 5,910,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,640,000 |
| 9 | ResearchAndDevelopmentExpense | 32,359,000 |
| 10 | remainder_Expenses | 75,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 32,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,984,000 |
| 1 | Liabilities | 5,910,000 |
| 2 | Expenses | 37,074,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 7,074,000 |
| 5 | NetIncome | -37,074,000 |
| 6 | ComprehensiveNetIncome | -37,058,000 |
| 7 | BaseVar | 28,000,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.29 |
| 9 | EconomicCapitalRatio | 0.927 |
Edgar->Model Mapping
Feature Distribution
